Launch Therapeutics
A clinical development company backed by Abingworth and Carlyle.
Founded in 2022, Launch Therapeutics offers pharmaceutical and biotech companies a variety of innovative models that combine access to capital with deep drug development, medical, clinical operations, regulatory, and commercialization expertise.
Latest Launch Therapeutics News & Features
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze